Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19864666rdf:typepubmed:Citationlld:pubmed
pubmed-article:19864666lifeskim:mentionsumls-concept:C0004364lld:lifeskim
pubmed-article:19864666lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:19864666lifeskim:mentionsumls-concept:C0027126lld:lifeskim
pubmed-article:19864666lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:19864666lifeskim:mentionsumls-concept:C0442821lld:lifeskim
pubmed-article:19864666pubmed:issue11lld:pubmed
pubmed-article:19864666pubmed:dateCreated2009-10-29lld:pubmed
pubmed-article:19864666pubmed:abstractTextMyotonic dystrophy type 2 (DM2) is a dominantly inherited multisystem disorder, characterised by progressive proximal weakness, myotonia, cataracts and cardiac conduction abnormalities. Our clinical impression of an association between DM2 and autoimmune diseases or autoantibody formation has not been published previously.lld:pubmed
pubmed-article:19864666pubmed:languageenglld:pubmed
pubmed-article:19864666pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19864666pubmed:citationSubsetIMlld:pubmed
pubmed-article:19864666pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19864666pubmed:statusMEDLINElld:pubmed
pubmed-article:19864666pubmed:monthNovlld:pubmed
pubmed-article:19864666pubmed:issn1468-330Xlld:pubmed
pubmed-article:19864666pubmed:authorpubmed-author:den...lld:pubmed
pubmed-article:19864666pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:19864666pubmed:authorpubmed-author:TielemanA AAAlld:pubmed
pubmed-article:19864666pubmed:authorpubmed-author:van de...lld:pubmed
pubmed-article:19864666pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19864666pubmed:volume80lld:pubmed
pubmed-article:19864666pubmed:ownerNLMlld:pubmed
pubmed-article:19864666pubmed:authorsCompleteYlld:pubmed
pubmed-article:19864666pubmed:pagination1293-5lld:pubmed
pubmed-article:19864666pubmed:meshHeadingpubmed-meshheading:19864666...lld:pubmed
pubmed-article:19864666pubmed:meshHeadingpubmed-meshheading:19864666...lld:pubmed
pubmed-article:19864666pubmed:meshHeadingpubmed-meshheading:19864666...lld:pubmed
pubmed-article:19864666pubmed:meshHeadingpubmed-meshheading:19864666...lld:pubmed
pubmed-article:19864666pubmed:meshHeadingpubmed-meshheading:19864666...lld:pubmed
pubmed-article:19864666pubmed:meshHeadingpubmed-meshheading:19864666...lld:pubmed
pubmed-article:19864666pubmed:meshHeadingpubmed-meshheading:19864666...lld:pubmed
pubmed-article:19864666pubmed:year2009lld:pubmed
pubmed-article:19864666pubmed:articleTitleStrong association between myotonic dystrophy type 2 and autoimmune diseases.lld:pubmed
pubmed-article:19864666pubmed:affiliationNeuromuscular Centre Nijmegen, Department of Neurology (935), Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. a.tieleman@neuro.umcn.nllld:pubmed
pubmed-article:19864666pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19864666pubmed:publicationTypeComparative Studylld:pubmed